13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurodegenerative Diseases
The study of neurodegenerative diseases delves into the intricate processes of neuronal decline and dysfunction, exploring the mechanisms behind disorders like amyotrophic lateral sclerosis, multiple sclerosis, and frontotemporal dementia. Cutting-edge research highlights the role of protein misfolding, mitochondrial dysfunction, and neuroinflammation in disease pathology. Therapies targeting these pathways, including small molecules, gene therapies, and stem cell-based treatments, are at the forefront of clinical trials. Efforts to integrate neuroimaging and computational models enhance the understanding of disease progression, enabling the design of precise therapeutic interventions. Collaborative advancements are reshaping the future of managing and potentially reversing the effects of these complex disorders.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Mapping the cytokine landscape in Alzheimer’s disease: A bibliometric analysis of global trends and emerging themes
Ananya Rajasekaran, ThinkNeuro, United States